Genetic linkage to the serotonin transporter protein and 5HT(2A) receptor genes excluded in generalized social phobia

Psychiatry Research

Volumn 81, Issue 3, 1998, Pages 283-291

  Stein, Murray B ^a,b   Chartier, Mariette J ^b   Kozak, Maria V ^b   King, Nicole ^c   Kennedy, James L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Pharmacotherapy; Selective serotonin reuptake inhibitors; Serotonin receptor

Indexed keywords

SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; GENETIC LINKAGE; HUMAN; OBSESSION; PANIC; PHOBIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PHENOTYPE; PHOBIC DISORDERS; POLYMERASE CHAIN REACTION; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0032517883     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00117-6     Document Type: Article

References (67)

1. American Psychiatric Association Task Force on DSM-IV, 1991. DSM-IV Options Book. American Psychiatric Press, Washington, DC.
2. Blum K., Braverman E.R., Wu S., Cull J.G.et al. Association of polymorphisms of dopamine D-2 receptor (DRD2) and dopamine transporter (DAT(1)) genes with schizoid/avoidant behaviors. Molecular Psychiatry. 2:1997;239-246.
3. Cavallini M.C., Di Bella D., Pasquale L., Henin M., Bellodi L. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Molecular Psychiatry. 2:1998;97-104.
4. Chapman, T.F., Mannuzza, S., Fyer, A.J., 1995. Epidemiology and family studies of social phobia. In: Heimberg, R.G., Liebowitz, M.R., Hope, D.A., Schneier, F.R. (Eds.), Social Phobia: Diagnosis, Assessment, and Treatment. Guilford Press, New York, pp. 21-39.
5. Clerget-Darpoux F., Bonaiti-Pellie C., Hochez J. Effects of misspecifying genetic parameters in lod score analysis. Biometrics. 24:1986;393-399.
6. Davidson J.R.T., Hughes D.C., George L.K., Blazer D.G. The boundary of social phobia: exploring the threshold. Archives of General Psychiatry. 51:1994;975-983.
7. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics. 81:1998;58-63.
8. Fyer A.J., Mannuzza S., Chapman T.F., Liebowitz M.R., Klein D.F. A direct interview family study of social phobia. Archives of General Psychiatry. 50:1993;286-293.
9. Fyer A.J., Mannuzza S., Chapman T.F., Martin L.Y., Klein D.F. Specificity in familial aggregation of phobic disorders. Archives of General Psychiatry. 52:1995;564-573.
10. Gelernter C.S., Stein M.B., Tancer M.E., Uhde T.W. An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder. Journal of Clinical Psychiatry. 53:1992;23-27.
11. Gelernter J., Pakstis A.J., Kidd K.K. Linkage mapping of the serotonin transporter protein gene SLC 6A4 on chromosome 17. Human Genetics. 95:1995;677-680.
12. Hazen, A.L., Stein, M.B., 1995. Clinical phenomenology and comorbidity. In: Stein, M.B. (Ed.), Social Phobia: Clinical and Research Perspectives. American Psychiatric Press, Washington, DC, pp. 3-42.
13. Heimberg R.G., Hope D.A., Dodge C.S., Becker R.E. DSM-III-R subtypes of social phobia. Journal of Nervous and Mental Disease. 178:1990;172-179.
14. Heimberg R.G., Holt C.S., Schneier F.R., Liebowitz M.R. The issue of subtypes in the diagnosis of social phobia. Journal of Anxiety Disorders. 7:1993;249-269.
15. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry. 66:1996;2621-2624.
16. Herbert J.D., Hope D.A., Bellack A.S. Validity of the distinction between generalized social phobia and avoidant personality disorder. Journal of Abnormal Psychology. 101:1992;332-339.
17. Holt C.S., Heimberg R.G., Hope D.A. Avoidant personality disorder and the generalized subtype of social phobia. Journal of Abnormal Psychology. 101:1992;318-325.
18. Jansen M.A., Arntz A., Merckelbach H., Mersch P.P.A. Personality disorders and features in social phobia and panic disorder. Journal of Abnormal Psychology. 103:1994;391-395.
19. Jefferson J.W. Social phobia: a pharmacologic treatment overview. Journal of Clinical Psychiatry. 56(5, suppl):1995;18-24.
20. Katzelnick D.J., Kobak K.A., Greist J.H., Jefferson J.W., Mantle J.M., Serlin R.C. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. American Journal of Psychiatry. 152:1995;1368-1371.
21. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. The genetic epidemiology of phobias in women: the interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Archives of General Psychiatry. 49:1992;273-281.
22. Kessler R.C., Stein M.B., Berglund P. Social phobia subtypes in the National Comorbidity Survey. American Journal of Psychiatry. 155:1998;613-619.
23. Kim S.W., Hoover K.M. Tridimensional Personality Questionnaire: assessment in patients with social phobia and a control group. Psychological Reports. 78:1996;43-49.
24. Knowles, J.A., Mannuzza, S., Fyer, A.J., 1995. Heritability of social phobia. In: Stein, M.B. (Ed.), Social Phobia: Clinical and Research Perspectives. American Psychiatric Press, Washington, DC., pp. 147-162.
25. Kruglyak L., Daly M.J., Reeve-Daly M.P., Lander E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. American Journal of Human Genetics. 58:1996;1347-1363.
26. Lahiri D.K., Nurnberger J.I. Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Research. 19:1991;5444.
27. Lathrop G.M., Lalouel J.M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proceedings of the National Academy of Sciences USA. 81:1984;3443-3446.
28. Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. Journal of Neural Transmission. 91:1993;67-72.
29. Lesch K.P., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Murphy D.L. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Research (Molecular Brain Research). 17:1993;31-36.
30. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., Riederer P. Organization of the human serotonin transporter gene. Journal of Neural Transmission. 95:1994;157-164.
31. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greeberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
32. Liebowitz M.R., Fyer A.J., Gorman J.M., Klein D.F. Social phobia: review of a neglected anxiety disorder. Archives of General Psychiatry. 42:1985;729-736.
33. Liebowitz M.R., Schneier F., Campeas R., Hollander E., Hatterer J., Fyer A., Gorman J., Papp L., Davies S., Gully R., Klein D.F. Phenelzine vs. atenolol in social phobia. Archives of General Psychiatry. 49:1992;290-300.
34. Magee W.J., Eaton W.W., Wittchen H.-U., McGonagle K.A., Kessler R.C. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry. 53:1996;159-168.
35. Mancini C., Van Ameringen M., Szatmari P., Fugere C., Boyle M. A high-risk pilot study of the children of adults with social phobia. Journal of the American Academy of Child and Adolescent Psychiatry. 35:1996;1511-1517.
36. Mannuzza S., Fyer A.J., Endicott J., Klein D.F. Schedule for Affective Disorders and Schizophrenia: Lifetime Version (modified for the study of anxiety disorders) (SADS-LA): rationale and conceptual development. Journal of Psychiatric Research. 20:1986;317-325.
37. Mannuzza S., Schneier F.R., Chapman T.F., Liebowitz M.R., Klein D.F., Fyer A.J. Generalized social phobia: reliability and validity. Archives of General Psychiatry. 52:1995;230-237.
38. Matsushita S., Muramatsu T., Kimura M., Shirakawa O., Mita T., Nakai T., Higuchi S. Serotonin transporter gene regulatory region polymorphism and panic disorder. Molecular Psychiatry. 2:1997;390-391.
39. McDougle C.J., Epperson C.N., Price L.H., Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Molecular Psychiatry. 3:1998;270-273.
40. Nakamura T., Muramatsu T., Ono Y., Matsushita S., Higuchi S., Mizushima H., Yoshimura K., Kanba S., Asai M. Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. American Journal of Medical Genetics (Neuropsychiatric Genetics). 74:1997;544-545.
41. Nelson E.C., Cloninger C.R., Przybeck T.R., Csernansky J.G. Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample. Biological Psychiatry. 40:1996;271-278.
42. Nicolini H., Cruz C., Camarena B., Orozco B., Kennedy J.L., King N., Weissbacker K., De La Fuente J.R., Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Molecular Psychiatry. 1:1996;461-465.
43. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwin G.M., Smith C.A.D. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 347:1996;731-733.
44. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proceedings of the National Academy of Sciences. 90:1993;2542-2546.
45. Reich J., Yates W. Family history of psychiatric disorders in social phobia. Comprehensive Psychiatry. 29:1988;72-75.
46. Risch N., Merikangas K. The future of genetics studies of complex human diseases. Science. 273:1996;1516-1517.
47. Schneier F.R., Spitzer R.L., Gibbon M., Fyer A.J., Liebowitz M.R. The relationship of social phobia subtypes and avoidant personality disorder. Comprehensive Psychiatry. 32:1991;496-502.
48. Rowe D.C., Stever C., Gard J.M., Cleveland H.H., Sanders M.L., Abramovitz A., Kozol S.T., Mohr J.H., Sherman S.L., Waldman I.D. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behavior Genetics. 28:1998;215-225.
49. Schneier F.R., Johnson J., Hornig C., Liebowitz M., Weissman M. Social phobia: comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry. 49:1992;282-288.
50. Schneier F.R., Heckelman L.R., Garfinkel R., Campeas R., Fallon B.A., Gitow A., Street L., Del Bene D., Liebowitz M.R. Functional impairment in social phobia. Journal of Clinical Psychiatry. 55:1994;322-331.
51. Schneier, F.R., 1995. Monoamine oxidase inhibitors and other antidepressants in the treatment of social phobia. In: Stein, M.B. (Ed.), Social Phobia: Clinical and Research Perspectives. American Psychiatric Press, Washington, DC, pp. 347-374.
52. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1990. Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P). American Psychiatric Press, Washington, DC.
53. Starcevic V., Uhlenhuth E.H., Fallon S., Pathak D. Personality dimensions in panic disorder and generalized anxiety disorder. Journal of Affective Disorders. 37:1996;75-79.
54. Stein M.B., Walker J.R., Forde D.R. Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety. American Journal of Psychiatry. 151:1994;408-412.
55. 3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers. Biological Psychiatry. 37:1995;224-228.
56. Stein M.B. How shy is too shy? Lancet. 347:1996;1131-1132.
57. Stein M.B., Chartier M.J., Hazen A.L., Kroft C.D.L., Chale R.A., Coté D., Walker J.R. An open-label clinical trial of paroxetine with a placebo-controlled discontinuation phase in patients with generalized social phobia. Journal of Clinical Psychopharmacology. 16:1996;218-222.
58. Stein M.B., Chartier M.J., Hazen A.L., Kozak M.V., Tancer M.E., Lander S., Chubaty D., Furer T., Walker J.R. A direct-interview family study of generalized social phobia. American Journal of Psychiatry. 155:1998;90-97.
59. Stein M.B., Liebowitz M.R., Lydiard R.B., Pitts C.D., Bushnell W., Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. Journal of the American Medical Association. 280:1998;708-713.
60. Tancer, M.E., Ranc, J., Golden, R.N., 1994/1995a. Pharmacological challenge test of the Tridimensional Personality Questionnaire in patients with social phobia and normal volunteers. Anxiety 1, 224-226.
61. Tancer, M.E., Mailman, R.B., Stein, M.B., Mason, G.A., Carson, S.W., Golden, R.N., 1994/1995b. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1, 216-223.
62. Tancer, M.E., Lewis, M.H., Stein, M.B., 1995. Biological aspects of social phobia. In: Stein, M.B. (Ed.), Social Phobia: Clinical and Research Perspectives. American Psychiatric Press, Washington, DC, pp. 229-257.
63. Tiihonen J., Kuikka J., Bergstrom K., Lepola U., Kopohen H., Leihonen E. Dopamine reuptake site densities in patients with social phobia. American Journal of Psychiatry. 154:1997;239-242.
64. van Vliet I.M., Den Boer J.A., Westenberg H.G.M. Psychopharmacological treatment of social phobia: a double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology. 115:1994;128-134.
65. Warren J.T. Jr., Peacock M.L., Fink J.K. An Msp I polymorphism in the human serotonin receptor gene (HTR2); detection by DGGE and RFLP analysis. Human Molecular Genetics. 2:1993;338.
66. Weeks D.E., Ott J., Lathrop G.M. SLINK: a general simulation program for linkage analysis. American Journal of Human Genetics. 43(suppl):1990;A204.
67. Weiller E., Bisserbe J.-C., Boyer P., Lepine J.-P., Lecrubier Y. Social phobia in general healthcare: an unrecognized undertreated disabling disorder. British Journal of Psychiatry. 168:1996;169-174.